Modulation of transcriptional activity of collagen genes for the treatment of fibrotic diseases

Bibliography

• JIMENEZ SA, HITRAYA E: Pathogenesis of Scleroderma: Collagen. Rheum. Dis. North Am. (1996) 22:647–674.
   PubMed Web of Science ®Google Scholar
• JIMENEZ SA, SAITTA B: Alterations in the regulation of expression of the al (I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Smith. Immurropathol (2000) 21:397–414.
   Web of Science ®Google Scholar
• SELMAN M, KING TE, PARDO A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. (2001) 134:136–151.
   PubMed Web of Science ®Google Scholar
• ALCOLADO R, ARTHUR MJ, IREDALE JP: Pathogenesis of liver fibrosis. Chi]. Sri. (1997) 92:103–112.
   Google Scholar
• NORMAN JT, FINE LG: Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp. Nephrol (1999) 7:167–177.
   PubMedGoogle Scholar
• KAHARI V, VUORIO T, NANTO-SALONEN K, VUORIO E: Increased Type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim. Biophys. Acta (1984) 781:183–186.
   PubMed Web of Science ®Google Scholar
• JIMENEZ SA, FELDMAN G, BASHEY RI, BIENKOWSKI R, ROSENBLOOM J: Co-ordinate increase in the expression of Type I and Type III collagen genes in progressive systemic sclerosis. Biochem. (1986) 237:837–843.
   Google Scholar
• HITRAYA EG, JIMENEZ SA: Transcriptional activation of the a(I) procollagen gene in systemic sclerosis dermal fibroblasts: role of intronic sequences. Arthritis Rheum. (1996) 39:1347–1354.
   PubMed Web of Science ®Google Scholar
• KAHARI V M, MULTIMAKI E VUORIO E: Elevated pro-a2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett. (1987) 215:331–334.
   PubMed Web of Science ®Google Scholar
• HERRMANN K, HECKMANN M, KULOZIK M, HAUSTEIN UF, KRIEG T: Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. j Invest. Dermatol (1991) 97:219–222.
   PubMed Web of Science ®Google Scholar
• KIKUCHI K, SMITH EA, LEROY EC, TROJANOWSKA M: Direct demonstration of transcriptional activation of collagen gene expression is systemic sclerosis fibroblasts. Biochem. Biophys. Res. Commun. (1992) 187:45–50.
   PubMed Web of Science ®Google Scholar
• ECKES B, MAUCH C, HUPPE G, KRIEG T: Differential regulation of transcription and transcript stability of proal(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic sclerosis. Biochem. J (1996) 315:549–554.
   PubMed Web of Science ®Google Scholar
• STEFANOVIC B, HELLERBRAND C, HOLCIK M, BRIENDL M, ALIEBHABER S, BRENNER DA: Post-translational regulation of collagen al (I) mRNA in hepatic stellate cells. Mal Cell. Biol. (1997) 17:5201–5209.
   Web of Science ®Google Scholar
• SLACK JL, LISKA DJ, BORNSTEIN P:Regulation of expression of the Type I collagen genes. Am. j Med. Genet. (1993) 45:140–151.
   PubMed Web of Science ®Google Scholar
• KARSENTY G, PARK RW: Regulation of Type I collagen genes expression. Int. Rev. Immurrol (1995) 12:177–185.
   PubMedGoogle Scholar
• BORNSTEIN P: Regulation of expression of the al (I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol. (1996) 15:3–10.
   PubMed Web of Science ®Google Scholar
• CHU M-L, DEWET W, RAMIREZ F: Fine structural analysis of the human pro-al (I) collagen gene. j Biol. Chem. (1985) 260:2315–2320.
   PubMed Web of Science ®Google Scholar
• ROUSSOUW CM, VERGEER WI DUPLOOY SJ, BERNARD MP, RAMIREZ D, DEWET WJ: DNA Sequences in the first intron of the human proal (I) collagen gene enhance transcription. J. Biol. Chem. (1987) 262:15151–15157.
   PubMed Web of Science ®Google Scholar
• BOASTS, SU MW, RAMIREZ F, SANCHEZ M, AVVEDIMENTO EV: Functional analysis of cis-acting DNA sequences controlling transcription of the human Type I collagen genes. I Biol. Chem. (1990) 265:13351–13356.
   Web of Science ®Google Scholar
• JIMENEZ SA, VARGA J, OLSEN A et al:Functional analysis of human al (I) procollagen gene promoter. Differential activity in collagen-producing and non-producing cells and response to transforming growth factor-PI. ..1 Biol. Chem. (1994) 269:12684–12691.
   Google Scholar
• ARTLETT CM, CHEN S-J, VARGA J, JIMENEZ SA: Modulation of basal expression of the human al (I) procollagen gene (COL1A1) by tandem NF-1/Spl promoter elements in normal human dermal fibroblasts. Matrix Biol. (1998) 171:425–434.
   Google Scholar
• COUREY AJ, TJIAN R: Analysis of Spl in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation domain. Cell (1988) 55:887–898.
   PubMed Web of Science ®Google Scholar
• LI L, ARTLETT CM, JIMENEZ SA, HALL DJ, VARGA J: Positive regulation of human al (I) collagen promoter activity by transcription factor Spl. Gene (1995) 164:229–234.
   PubMed Web of Science ®Google Scholar
• NEHLS MC, RIPPE RA, VELOZ L, BRENNER DA: Transcription factors nuclear Factor I and Spl interact with the murine collagen al (I) promoter. Mal Cell. Biol. (1991) 11:4065–4073
   Web of Science ®Google Scholar
• NEHLS MC, GRAPILON ML, BRENNER DA: NF-1/Spl switch elements regulate collagen al (I) gene expression. DNA Cell Biol. (1992) 11:443–452.
   PubMed Web of Science ®Google Scholar
• POPPLETON HM, RAGHOW R: Transcriptional activation of the minimal human proal (I) collagen promoter: obligatory requirement for Spl. Biochem. (1997) 323:225–231.
   Google Scholar
• CHEN S-J, ARTLETT CM, JIMENEZ SA, VARGA J: Modulation of human al (I) procollagen gene activity by interaction with Spl and Sp3 transcription factors in vitro. Gene (1998) 215:101–110.
   PubMed Web of Science ®Google Scholar
• HITRAYA EG, VARGA J, ARTLETT CM, JIMENEZ SA: Identification of elements in the promoter of the al (I) procollagen gene involved in its upregulated expression in systemic sclerosis. Arthritis Rheum. (1998) 41:2048–2058.
   PubMed Web of Science ®Google Scholar
• IHN H, TAMAKI K: Increased phosphorylation of transcription factor Spl in scleroderma fibroblasts: association with increased expression of the Type I collagen gene. Arthritis Rheum. (2000) 43:2240–2247.
   PubMed Web of Science ®Google Scholar
• RIPPE RA, ALMOUNAJED G, BRENNER D: Spl binding activity increases in activated Ito cells. Hepatology (1995) 22:241–251.
   PubMed Web of Science ®Google Scholar
• INAGAKI Y, TRUTER S, RAMIREZ F: Transforming growth factor-I3 stimulates a2(I) collagen gene expression through a as-acting element that contains an Spl-binding site. j Biol. Chem. (1994) 269:14826–14834.
   Web of Science ®Google Scholar
• CHEN S-J, YUAN W, MORI Y, LEVENSON A, TROJANOWSKA M, VARGA J: Stimulation of Type I collagen transcription in human skin fibroblasts by TGF-P: involvement of Smad 3. j Invest. Dermatol (1999) 112:49–57.
   PubMed Web of Science ®Google Scholar
• ZHANG W, OU J, INAGAKI Y, GREEN WEL P, RAMIREZ F: Synergistic cooperation between Spl and Smad3/ Smad4 mediates transforming growth factor 131 stimulation of a2(I)-collagen (COL 1A2) transcription. I Biol. Chem. (2000) 275:39237–39245.
   Web of Science ®Google Scholar
• VERRECCHIA E ROSSERT J, MAUVIEL A: Blocking Spl transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. j Invest. Dermatol (2001) 116:755–763.
   PubMed Web of Science ®Google Scholar
• NEHLS MC, BRENNER DA, GRUSS HJ,DIERBACH H, MERTELSMANN R, HERRMANN I: Mithramycin selectively inhibits collagen al (I) gene expression in human fibroblasts. j Clin. Invest. (1993) 92:2916–2921.
   PubMed Web of Science ®Google Scholar
• GAIDAROVA S, JIMENEZ SA: Inhibition of al (I) collagen gene (COL1A1) expression in systemic sclerosis (SSc) fibroblasts by the Spl binding drugs WP631 and mithoxanthrone. Arthritis Rheum. (2001):44:S192.
   Google Scholar
• COUSTRY E SINHA S, MAITY SN, DE CROMBRUGGHE B: The two activation domains of the CCAAT-binding factor CBF interact with the dTAF11110 component of the Drosophila TFIID complex. Biochem. (1998) 331:291–297.
   Google Scholar
• KADONAGA JT, CARNER MASAIRZ FR, TJIAN R: Isolation of cDNA encoding transcription factor Spl and functional analysis of the DNA binding domain. Cell (1987) 51:1079–1090.
   PubMed Web of Science ®Google Scholar
• TAMAKI T, OHNISHI K, HARTL C, LEROY EC, TROJANOWSKA M: Characterization of GC-rich region containing Spl binding site(s) as a constitutive responsive element of the a2(I) collagen gene in human fibroblasts. I Biol. Chem. (1995) 270:4299–4303.
   Web of Science ®Google Scholar
• IHN H, TROJANOWSKA M: Sp3 is a transcriptional activator of the human a2 (I) collagen gene. Nucleic Acid Res. (1997) 25:3712–3717.
   PubMed Web of Science ®Google Scholar
• IHN H, OHNISHI K, TAMAKI T, LEROY EC, TROJANOWSKA M: Transcriptional regulation of the human a2(I) collagen gene. I Biol. Chem. (1996) 271:26717–26723.
   Web of Science ®Google Scholar
• SAITTA B, GAIDAROVA S, CICCHILLITTI L, JIMENEZ SA: CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts. Arthritis Rheum. (2000) 43:2219–2229.
   PubMed Web of Science ®Google Scholar
• SAITTA B, LOUNEVA NM, JIMENEZ SA: The novel anticancer agent, ecteinascidin 743 (ET-743), causes potent inhibition of COL1A1 transcription in systemic sclerosis (scleroderma) fibroblasts. Arthritis Rheum. (2001) 44:S181.
   Google Scholar
• LOUNEVA NM, JIMENEZ SA, SAITTA B: Inhibition of expression of several extracellular matrix genes in normal and systemic sclerosis fibroblasts by ecteinascidin 743. Arthritis Rheum. (2001) 44:S193.
   Google Scholar
• GALERA P, MUSSO M, DUCY P, KARSENTY G: c-Krox, a transcriptional regulator of Type I collagen gene expression, is preferentially expressed in skin. Proc. Nati Acad. Sci. USA (1994) 91:9372–9376.
   PubMed Web of Science ®Google Scholar
• GALERAP, PARK RW, DUCYP, MATTEI MG, KARSENTY G: c-Krox binds to several sites in the promoter of both mouse Type I collagen genes. I Biol. Chem. (1996) 271:21331–21339.
   Web of Science ®Google Scholar
• WIDOM RL, CULIC I, LEE JY, KORN JH: Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene (1997) 198:407–420.
   PubMed Web of Science ®Google Scholar
• KATAI H, STEPHENSON JD, SIMKEVICH CP, THOMPSON JP, RAGHOW R: An AP-1-like motif in the first intron of human pro-al (I) collagen gene is a critical determinant of its transcriptional activity. Mal Cell. Biochem. (1992) 118:119–129.
   PubMed Web of Science ®Google Scholar
• STRUHL K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. (1998) 12:599–606.
   PubMed Web of Science ®Google Scholar
• NIKI T, ROMBOUTS K, DE BLESER P etal.: A histone deacetylase inhibitor, trichostatin A, suppresses transdifferentiation of cultured rat hepatic stellate cells. Hepatology (1999) 29:859–867.
   Google Scholar
• ROMBOUTS K, NIKI T, WIELANT A, HELLEMANS K, GEERTS A: Trichostatin A, lead compound for development of antifibrogenic drugs. Acta Castroenterol Belg. (2001) 64:239–246.
   PubMed Web of Science ®Google Scholar
• GRAY SG, EKSTROM TJ: The human histone deacetylase family. Exp. Cell Res. (2001) 262:75–83.
   PubMed Web of Science ®Google Scholar
• MARKS PA, RICHON VM, BRESLOW R, RIFKIND RA: Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol (2001) 13:477–483.
   PubMed Web of Science ®Google Scholar
• KOMATSU Y, TOMIZAKI KY, TSUKAMOTO M et al.: Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Res. (2001) 61:4459–4466.
   PubMed Web of Science ®Google Scholar
• GRANOT I, BARTOV I, PLAVNIK I, WAX E, HURWITZ S, PINES M: Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone. Pou/t. Sci. (1991) 70:1559–1563.
   PubMed Web of Science ®Google Scholar
• GRANOT I, HALEVY O, HURWITZ S, PINES M: Halofuginone: an inhibitor of collagen Type I synthesis. Biochim. Biophys. Acta (1993) 1156:107–112.
   PubMed Web of Science ®Google Scholar
• PINES M, NAGLER A: Halofuginone: a novel antifibrotic therapy. Gen. Pharmacol (1998) 30:445–450.
   PubMedGoogle Scholar
• JOSEPH J, KANDALA JC, VEERAPANANE D, WEBER KT, GUNTAKA RV: Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat al (I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Nucleic Acids Res. (1997) 25:2182–2188.
   PubMed Web of Science ®Google Scholar
• RIRIE SS, GUNTAKA RV: An RNA oligonucleotide corresponding to the polypyrimidine region of the rat al (I) procollagen promoter forms a stable triplex and inhibits transcription. Biochim. Biophys. Res. Commun. (1998) 10:218–221.
   Google Scholar
• NAKANISHI M, WEBER KT, GUNTAKA RV: Triple helix formation with the promoter of human al (I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide. Nucleic Acids Res. (1998) 26:5218–5222.
   PubMed Web of Science ®Google Scholar
• GAMBARO G, WEIGERT C, CEOL M, SCHLEICHER ED: Inhibition of transforming growth factor-I31 gene overexpression as a strategy to prevent fibrosis. Contrib. Nephrol (2001) 131:107–113.
   Web of Science ®Google Scholar
• BLOBE GC, SCHIEMANN EP, LODISH HF: Role of transforming growth factor 13 in human disease. N Engl. J. Med. (2000) 342:1350–1358.
   PubMed Web of Science ®Google Scholar
• BRANTON MH, KOPP JB: TGF-I3 and fibrosis. Microbes Infect. (1999) 1:1349–1365.
   PubMed Web of Science ®Google Scholar
• WELLS RG: Fibrogenesis. V. TGF-I3 signaling pathways. Am. J. Physiol (2000) 279:G845–G850.
   Google Scholar
• PIEK E, HELDIN CH, TEN DUKE P: Specificity, diversity and regulation in TGF-13signaling. FASEB J. (1999)13:2105–2124.
   PubMed Web of Science ®Google Scholar
• ULLOA L, DOODY J, MASSAGUE J: Inhibition of transforming growth factor-I3/ SMAD signalling by the interferon-y/STAT pathway. Nature (1999) 397:710–713.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, FENG XH, DERYNCK R: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-I3-induced transcription. Nature (1998) 394:909–913.
   PubMed Web of Science ®Google Scholar